Stock market anomaly: Kangzhe Pharmaceutical (00867.HK) rose more than 3%. The application for the market approval of ZUNVEYL new drug has been accepted by the National Medical Products Administration.

Zhixin Finance APP learned that Kangzhe Pharmaceutical (00867.HK) surged more than 3%, as of the time of publication, it was up 2.84% at 13.78 Hong Kong dollars, with a turnover of 71.64 million Hong Kong dollars.